Panacos Pharmaceuticals, Inc. (NASDAQOTH:PANC.PK)
CAPS Rating:
A development stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other major human viral diseases.
RSS Headlines
Fool UK